Conclusion: Only cryoablation met the requirement to proceed to a phase 3 study, with an efficacy rate of 94%, a complication rate of 0%, and a 100% treatment tolerance. 94% of patients were very ...

Adagio’s vCLASTM Cryoablation System, which is currently the subject of an Investigational Device Exemption (“IDE”) study called FULCRUM-VT, is a purpose-built system using the Company’s ...

SINGLE SHOT CHAMPION Trial PFA has emerged in recent years as an alternative to thermal modalities, including radiofrequency and cryoablation. It’s touted as a safer option because its mechanism of ...

External beam radiation therapy and cryoablation can both be used to treat localized prostate cancer. Quality of life outcomes are similar with the two forms of treatment, with the exception of ...

Pulsed field ablation using Boston Scientific Corp.’s Farapulse system was non-inferior and even superior, slightly, to Medtronic plc’s Artic Front Advance cardiac cryoablation system in treating ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

IceCure Medical ICCM presented interim results from its ICESECRET kidney cancer cryoablation study at the European Association of Urology Conference in Spain. The study reported an 88.7% ...

Under the program, the FDA will provide Adagio with priority review and interactive communication during the vCLAS TM Cryoablation System premarket review phase. VT is a rapid, abnormal heart ...

Adagio’s vCLAS TM Cryoablation System, which is currently the subject of an Investigational Device Exemption ("IDE") study called FULCRUM-VT, is a purpose-built system using the Company’s proprietary ...